What connects the opioid crisis, football players’ concussion risks, and climate change? A playbook created by the tobacco industry that relies on denying evidence of harms to public health.
The nationwide financial squeeze on federal employees, contractors, and the businesses that depend on them may be the most visible harm from the ongoing partial government shutdown, but we should also be aware of damage to science. The shutdown has furloughed federal scientists, stalled data collection, weakened scientific meetings, left current and potential collaborators hanging, […]
The day after Thanksgiving, the White House made public the Fourth National Climate Assessment, Volume II. Congress has mandated that these reports be released every four years, and the Trump administration seemingly figured that doing so on the day after Thanksgiving would limit public attention.
Following Hurricane Florence, North Carolina residents face health risks from livestock waste that’s been spilling from flooded containment enclosures.
If all countries met World Health Organization standards for fine particulate air pollution, life expectancy gains could be similar in scale to eradicating breast and lung cancer.
The Ninth Circuit Court of Appeals orders EPA to ban the neurotoxic pesticide chlorpyrifos because the evidence shows that it’s harmful.
Is human nature really the primary reason the U.S. has failed to take the kind of action needed to prevent climate disaster?
Helping journalists, staffers stealthily collected dust samples from a busy hallway in an urban elementary school in Philadelphia. When sky-high asbestos results came back from the lab, the journalists, both Pulitzer Prize winners, faced an ethical and moral dilemma unlike any other they had encountered in their long careers.
Last week, EPA held a hearing about its proposed rule to restrict the research it can use in regulating, and scores of public health advocates attended to speak out against it.
A proposed EPA rule that would sharply restrict the studies the agency can use when regulating faces pushback from the agency’s Science Advisory Board and a bipartisan group of more than 100 Congress members. The agency has extended the comment period and scheduled a hearing, but still seems determined to move ahead with a deeply flawed rule.